Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Behbehani

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|December 30, 2022
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T LymphocytesYaya Chu, Jordan Milner, Margaret Lamb, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
JCI Insight|March 20, 2020
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host diseaseKatiri J Snyder, Nina C Zitzer, Yandi Gao, et al.
Neuro-Oncology|March 11, 2020
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymomaSoumen Khatua, Laurence J N Cooper, David I Sandberg, et al.
International Journal of Molecular Sciences|July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic CancerJustin Thomas, Molly A Torok, Kriti Agrawal, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Quality in Primary Care|March 5, 2014
The Kuwait-Scotland eHealth Innovation Network (KSeHIN): a sustainable approach to quality improvement in healthcareN T Conway, R Al Wotayan, A Alkuzam, et al.
Cancers|June 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative DisorderElshafa Hassan Ahmed, Mark Lustberg, Claire Hale, et al.
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|December 30, 2022
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T LymphocytesYaya Chu, Jordan Milner, Margaret Lamb, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
JCI Insight|March 20, 2020
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host diseaseKatiri J Snyder, Nina C Zitzer, Yandi Gao, et al.
Neuro-Oncology|March 11, 2020
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymomaSoumen Khatua, Laurence J N Cooper, David I Sandberg, et al.
International Journal of Molecular Sciences|July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic CancerJustin Thomas, Molly A Torok, Kriti Agrawal, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Quality in Primary Care|March 5, 2014
The Kuwait-Scotland eHealth Innovation Network (KSeHIN): a sustainable approach to quality improvement in healthcareN T Conway, R Al Wotayan, A Alkuzam, et al.
Cancers|June 10, 2023
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative DisorderElshafa Hassan Ahmed, Mark Lustberg, Claire Hale, et al.
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemiaDimitrios Papaioannou, Changxian Shen, Deedra Nicolet, et al.
Pageof 12